Growth Metrics

Regenerex Pharma (RGPX) Share-based Compensation (2011 - 2025)

Regenerex Pharma (RGPX) reported Share-based Compensation of $177867.0 for Q3 2025, up 396.86% year-over-year from $35798.0 in Q3 2024, and down 30.83% on a QoQ basis from $257133.0 in Q2 2025.

Regenerex Pharma (RGPX) has 7 years of Share-based Compensation data on file, last reported at $177867.0 in Q3 2025.

  • Quarterly Share-based Compensation rose 396.86% year-over-year to $177867.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $510867.0 (up 328.37% YoY) and the FY2025 annual result came in at $132662.0, down 37.33% from the prior year.
  • Share-based Compensation fell to $177867.0 in Q3 2025 per RGPX's latest filing, from $257133.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $257133.0 in Q2 2025 and bottomed at $5400.0 in Q4 2023.
  • The 3-year median for Share-based Compensation is $46431.0 (2024), against an average of $76351.4.
  • The widest annual swing landed in 2024, when Share-based Compensation slumped 63.78%; it then surged 1124.62% in 2025.
  • Tracing RGPX's Share-based Compensation over 3 years: stood at $5400.0 in 2023, then surged by 232.83% to $17973.0 in 2024, then soared by 889.63% to $177867.0 in 2025.
  • Per Business Quant, the three latest RGPX Share-based Compensation figures stand at $177867.0 (Q3 2025), $257133.0 (Q2 2025), and $57894.0 (Q1 2025).

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 177,867.00
Sep 30, 2025 177,867.00
Jun 30, 2025 257,133.00
Jun 30, 2025 257,133.00
Mar 31, 2025 57,894.00
Mar 31, 2025 57,894.00
Dec 31, 2024 17,973.00
Dec 31, 2024 17,973.00
Sep 30, 2024 35,798.00
Sep 30, 2024 35,798.00
Jun 30, 2024 20,997.00
Jun 30, 2024 20,997.00
Mar 31, 2024 57,064.00
Mar 31, 2024 57,064.00
Dec 31, 2023 5,400.00
Dec 31, 2023 5,400.00
Sep 30, 2023 98,834.00
Sep 30, 2023 98,834.00
Jun 30, 2023 34,554.00
Jun 30, 2023 34,554.00
Dec 31, 2018 45,000.00
Dec 31, 2018 45,000.00
Aug 31, 2013 25,000.00
Aug 31, 2013 25,000.00
May 31, 2013 20,000.00
May 31, 2013 20,000.00
Aug 31, 2012 5,000.00
Aug 31, 2012 5,000.00
May 31, 2012 5,000.00
May 31, 2012 5,000.00
Feb 29, 2012 20,000.00
Feb 29, 2012 20,000.00
Aug 31, 2011 375,000.00
Aug 31, 2011 375,000.00